Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin CLesley A. Inker, Andrew S. Levey, Christopher H. Schmid et al.|New England Journal of Medicine|2012Cited by 4.1k
Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the communityGuruprasad Manjunath, Mark J. Sarnak, Hocine Tighiouart et al.|Journal of the American College of Cardiology|2002Cited by 916
Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines AgencyAndrew S. Levey, Kerry Willis, Ron T. Gansevoort et al.|American Journal of Kidney Diseases|2019Cited by 561
Level of kidney function as a risk factor for cardiovascular outcomes in the elderlyGuruprasad Manjunath, Mark J. Sarnak, Hocine Tighiouart et al.|Kidney International|2003Cited by 467
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trialsHiddo J.L. Heerspink, Tom Greene, Hocine Tighiouart et al.|The Lancet Diabetes & Endocrinology|2019Cited by 372